Caprock Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Buy
+25,633
New +$171K ﹤0.01% 1141
2026
Q1
Sell
-19,793
Closed -$139K 1286
2025
Q4
$139K Sell
19,793
-6,148
-24% -$48.1K ﹤0.01% 1140
2025
Q3
$201K Buy
+25,941
New +$202K ﹤0.01% 1069
2025
Q1
$292K Buy
+36,648
New +$371K 0.01% 877
2020
Q4
Sell
-2,110
Closed -$463K 494
2020
Q3
$463K Buy
2,110
+125
+6% +$26.5K 0.06% 220
2020
Q2
$379K Buy
+1,985
New +$348K 0.06% 238

Other funds holding TDOC

Caprock Group's TDOC Position: Q2 2026 in Review

Caprock Group opened a new position in Teladoc Health (TDOC) in Q2 2026: 25,633 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1141 among its holdings. This is a return to the name: Caprock Group previously reported a position in TDOC as recently as Q4 2025.

Caprock Group first reported a position in TDOC in Q2 2020 and has held it in 6 quarters since. The position peaked at $463K in Q3 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Caprock Group held 25,633 shares of Teladoc Health worth $217K as of Q2 2026.
  • Teladoc Health was a new Caprock Group position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1141 holding.
  • Caprock Group first reported a position in Teladoc Health in Q2 2020 and has held it in 6 quarters since.
  • Caprock Group's Teladoc Health position peaked at $463K in Q3 2020.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.